split product

Fibrin split products, a test of clotting dysfunction in human physiology.

It converts plasminogen to plasmin, which in turn degrades fibrin (blood clots) to fibrin split products.

Fibrin degradation product (FDPs), also known as fibrin split products, are components of the blood produced by clot degeneration.

Rhamnetin, a splitting product of the glucosides of Rhamnus, is monomethyl quercetin; fisetin, from Rhus cotinus, is monoxyquercetin; chrysin is phenyl-dioxybenzo-y-pyrone.

The breakdown of fibrinogen and fibrin results in polypeptides called fibrin degradation products (FDPs) or fibrin split products (FSPs).

A more specific test is for "fibrin split products" (FSPs) or "fibrin degradation products" (FDPs) which are produced when fibrin undergoes degradation when blood clots are dissolved by fibrinolysis.

Cryofibrinogenemia is defined by the presence of circulating cold insoluble complexes of fibrin, fibrinogen, fibronectin, and fibrin split products with albumin, immunoglobulins and plasma proteins that precipitate from the patient's plasma in the cold.